Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
| Autor: | Alba Rodríguez-Nogales, M. Angeles Ocete, Julio Gálvez, S. Risco, M. Elena Rodríguez-Cabezas, Francesca Algieri |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Immunology Artemisia absinthium Life quality Review Article Disease Pharmacology Inflammatory bowel disease Curcuma lcsh:Pathology medicine Humans Boswellia Aloe Adverse effect Intensive care medicine Beneficial effects Cannabis Plant Extracts business.industry Cell Biology Inflammatory Bowel Diseases medicine.disease Ulcerative colitis digestive system diseases Clinical trial Etiology Andrographis business lcsh:RB1-214 Phytotherapy |
| Zdroj: | Mediators of Inflammation Mediators of Inflammation, Vol 2015 (2015) |
| ISSN: | 1466-1861 0962-9351 |
| Popis: | Crohn’s disease and ulcerative colitis are the two most common categories of inflammatory bowel disease (IBD), which are characterized by chronic inflammation of the intestine that comprises the patients’ life quality and requires sustained pharmacological and surgical treatments. Since their aetiology is not completely understood, nonfully efficient drugs have been developed and those that show effectiveness are not devoid of quite important adverse effects that impair their long-term use. Therefore, many patients try with some botanical drugs, which are safe and efficient after many years of use. However, it is necessary to properly evaluate these therapies to consider a new strategy for human IBD. In this report we have reviewed the main botanical drugs that have been assessed in clinical trials in human IBD and the mechanisms and the active compounds proposed for their beneficial effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|